Full text is available at the source.
Abstract
In 2023, nephrology studies revealed diverse findings regarding chronic kidney disease and cardiovascular disease management.
- Finerenone use may influence the progression of chronic kidney disease and cardiovascular disease.
- Magnesium supplementation and iron markers were also examined for their potential impact on disease progression.
- Daprodustat may improve anemia management in patients with chronic kidney disease.
- Patiromer is associated with addressing hyperphosphatemia in chronic kidney disease management.
- Acetazolamide combined with loop diuretics could enhance diuresis in patients with acute decompensated heart failure.
- Once-daily hydrochlorothiazide did not prevent the recurrence of kidney stones.
Simplified